ANTISENSE COMPOUNDS AND METHODS FOR TARGETING CUG REDUCTIVES
Compounds comprising cyclic peptides, such as cyclic cell penetrating peptides, and antisense compounds are provided. The antisense compound binds to a gene having an amplified CTG repetitive sequence or a gene transcript having an amplified CUG repetitive sequence. The compounds may be delivered to...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
30.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | Compounds comprising cyclic peptides, such as cyclic cell penetrating peptides, and antisense compounds are provided. The antisense compound binds to a gene having an amplified CTG repetitive sequence or a gene transcript having an amplified CUG repetitive sequence. The compounds may be delivered to a subject to treat diseases associated with amplified CTG.CUG repetitions, such as type 1 ankylosing muscular dystrophy (DMI), spinal cerebellar ataxial-8 (SCA8), and Huntington's Disease-2 (HDL2).
提供了包含环肽诸如环状细胞穿透肽及反义化合物的化合物。所述反义化合物与具有扩增的CTG重复序列的基因或具有扩增的CUG重复序列的基因转录物结合。所述化合物可递送至受试者以治疗与扩增的CTG·CUG重复序列相关的疾病,诸如1型强直性肌营养不良(DM1)、脊髓小脑性共济失调-8(SCA8)和亨廷顿病样-2(HDL2)。 |
---|---|
Bibliography: | Application Number: CN202280056925 |